Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.60
Bid: 9.62
Ask: 10.08
Change: 0.00 (0.00%)
Spread: 0.46 (4.782%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.60
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer of securities contingently convertible

29 Aug 2019 07:00

RNS Number : 4827K
Banco Bilbao Vizcaya Argentaria SA
28 August 2019
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, and further to the inside information dated 27 August 2019, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

 

BBVA has agreed to carry out an issue of preferred securities contingently convertible into newly issued ordinary shares of BBVA with exclusion of pre-emptive subscription rights for shareholders (the "Securities") for a total nominal amount of 1,000,000,000 US Dollars (the "Issuance").

 

Once fully paid-up, the Securities are expected to qualify as Additional Tier 1 Capital of BBVA and its Group pursuant to the applicable solvency regulations.

 

The remuneration of the Securities, whose payment is discretionary and subject to certain conditions, has been set at 6.5% on an annual basis until 5 March 2025. After that, it will be reviewed in accordance with the applicable terms and conditions of the Issuance by applying a margin of 519.2 basis points on the 5-year UST.

 

The Issuance is in no event directed towards retail investors and the Securities shall not be offered, distributed or sold in Spain or to Spanish tax residents, without prejudice to the additional sales restrictions set out in the terms and conditions of the Issuance.

 

BBVA will request the listing of the Securities on the Global Exchange Market of Euronext Dublin.

 

Furthermore, BBVA informs that, for the purposes set out in articles 414, 417 and 511 of the Corporate Enterprises Act, the director's report and the report of the independent expert/auditor of accounts different from BBVA's auditor, both related to the Issuance, have been issued. These reports will be available to shareholders through their publication on BBVA's website (www.bbva.com) on the Issuance closing date (expected to take place on 5 September 2019) and will be reported to the first General Shareholders' Meeting to be held after the Issuance.

 

Madrid, 28 August 2019

 

Important information:

There are restrictions with respect to the offering of the Securities in various jurisdictions, including the United Kingdom, Spain, Japan, Singapore, Hong Kong, Canada, Switzerland and the European Economic Area.

This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

This document is not a prospectus and is not an offer or a solicitation to buy, sell, subscribe or exchange any securities issued or to be issued by BBVA. No such offer in relation to the Securities shall be conducted in any jurisdiction in which said offer is not made in conformity with the applicable legislation.

This document is not an offer for sale of securities in the United States and the Securities may not be offered or sold in the United States nor to, on behalf or for the benefit of, any citizen of the United States, as defined in the Regulation S of the US Securities Act of 1933, as amended ("US Securities Act"), unless such Issuance is registered or falls under an exception of registration pursuant the US Securities Act.

In relation with the Issuance, BBVA has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents BBVA has filed with the SEC for more complete information about BBVA and the Issuance. You may obtain these documents for free by visiting the SEC web site at www.sec.gov.

This announcement is not a prospectus but rather is an announcement, and investors should not subscribe for any Securities except on the basis of the information contained in the prospectus, the prospectus supplement and the other documents filed by BBVA with the SEC that are incorporated by reference in the registration statement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLFFFLTFITFIA
Date   Source Headline
12th Apr 20179:35 amRNSPost Stabilisation Notice
12th Apr 20179:24 amRNSPre Stabilisation Notice
5th Apr 20174:51 pmRNSFinal Terms GMTN Programme
3rd Apr 20179:31 amRNSPre Stabilisation Notice
30th Mar 20177:00 amRNSDividend Option Information April 2017
22nd Mar 20178:12 amRNSBBVA completes the acquisition of 9.95% of Garanti
20th Mar 20177:00 amRNSBasel Accord Pillar III
17th Mar 20173:05 pmRNSDividend Option April 2017
17th Mar 20172:58 pmRNSResolutions adopted by the General Meeting
16th Mar 20171:36 pmRNSFinal Terms GMTN Programme
14th Mar 20173:55 pmRNSFinal Terms GMTN Programme
8th Mar 201711:36 amRNSDBRS has assigned BBVA an Issuer Rating
24th Feb 20173:49 pmRNSSupplemental to the Offering Circular GMTN
24th Feb 201710:29 amRNSFinal Terms GMTN Programme
22nd Feb 20177:00 amRNSAcquisition agreement 9,95% of Garanti
14th Feb 20174:07 pmRNSSupplemental to the Offering Circular
14th Feb 20171:26 pmRNSBBVA Annual Report 2016 (spanish version)
14th Feb 20171:22 pmRNSBBVA Annual Report 2016
14th Feb 20179:06 amRNSNotice of AGM
10th Feb 20177:00 amRNSAnnual General Meeting 2017 Call
8th Feb 20173:04 pmRNSFinal Terms - Global Medium Term Note Programme
6th Feb 201710:15 amRNSPost-Stab Notice BBVA EUR 5yr Senior
3rd Feb 20173:34 pmRNSStabilisation Notice
2nd Feb 20178:37 amRNSStabilisation Notice - BBVA T2
1st Feb 20174:36 pmRNSSupplemental to the Offering Circular
1st Feb 20177:16 amRNS4Q16 Results Presentation
1st Feb 20177:10 amRNS4Q16 Results Report
1st Feb 20177:05 amRNSPress Release 4Q16 Results
1st Feb 20177:00 amRNSShareholder Remuneration Policy
27th Jan 20177:48 amRNS4Q16 Results presentation announcement
23rd Jan 20177:46 amRNSRDL Mortgage Floor Clauses
11th Jan 201712:09 pmRNSFinal Terms Global Medium Term Note Programme
5th Jan 201710:10 amRNSPre Stabilisation Notice BBVA EUR 5yr Senior
4th Jan 20173:21 pmRNSPublication of Approved ECP Supplement
28th Dec 20167:00 amRNSSupplemental to the Offering Circular
22nd Dec 20163:51 pmRNSPublication of approved ECP Listing Particulars
22nd Dec 20167:00 amRNSDividend January 2017
21st Dec 20162:23 pmRNSMortgage Floor Clauses
19th Dec 201610:43 amRNSSupplemental to the Offering Circular
1st Dec 20167:48 amRNSSREP capital requirement
25th Nov 20161:24 pmRNSOffering Circular
23rd Nov 20165:44 pmRNSBBVA SA Annual Report 2015
23rd Nov 20165:28 pmRNSBBVA SA Annual Report 2014
23rd Nov 20165:19 pmRNSForm 6-K
23rd Nov 20165:04 pmRNSForm 20-F 2015
7th Nov 20163:32 pmRNSSupplemental to the Offering Circular
4th Nov 201612:18 pmRNSDividend Option
27th Oct 20167:00 amRNS3rd Quarter Results Presentation
27th Oct 20167:00 amRNS3rd Quarter Results Information
27th Oct 20167:00 amRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.